Study of haridradi churna in the management of Tamak Shwasa

OPEN RANDOMIZED CONTROL CLINICAL STUDY ON EFFICACY OF HARIDRADI CHURNA IN THE MANAGEMENT OF TAMAK SHWASA

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/02/023482

Enrollment

104

Registered

2020-02-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

Interventions

Intervention1: Haridradi Churna: 2gm bd 21 days orally Control Intervention1: Elaadi Churna: 2 gm bd 21 days orally

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with classical features of Tamaka Shwasa that is Shwasa krucchata Peenasa Ghurghuratwam Sakapha kasa Shwasa vega Patients with history of Tamaka shwasa less than 5 years

Exclusion criteria

Exclusion criteria: Patients aged less than 16 years and more than 60 years Patients with history of Tamak shwasa more than 5 years Patient presenting with Tamak shwasa due to the complication of other systemic diseases like Pneumonia Tuberculosis Lung carcinoma Cardiac asthma will be excluded Pregnant womens and lactating mothers will be excluded Emergency condition of the patient who requires oxygen inhalation

Design outcomes

Primary

Measure	Time frame
TO STUDY THE EFFICACY OF HARIDRADI CHURNA IN THE MANAGEMENT OF TAMAK SHWASATimepoint: 18 MONTHS	—

Secondary

Measure	Time frame
TO STUDY THE MODE OF ACTION OF HARIDRADI CHURNATimepoint: 21 DAYS	—

Countries

India

Contacts

Public ContactDr Dattatray Nikam

Hon Shri Annasaheb Dange Ayurved Medical College And Post Graduate Research Training Center Ashta

drdattatryanikam@yahoo.com8390761674

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026